[1]Patent:WO2012/177618,2012,A1.Locationinpatent:Page/Pagecolumn49
[2]JournalofMedicinalChemistry,2014,vol.57,p.4173-4184
[3]Patent:WO2015/167825,2015,A1.Locationinpatent:Page/Pagecolumn92
[1]Ganesh,Thota;Jiang,Jianxiong;Yang,Myung-Soon;Dingledine,Ray[JournalofMedicinalChemistry,2014,vol.57,#10,p.4173-4184]
[1]Ganesh,Thota;Jiang,Jianxiong;Yang,Myung-Soon;Dingledine,Ray[JournalofMedicinalChemistry,2014,vol.57,#10,p.4173-4184]
[2]CurrentPatentAssignee:EMORYUNIVERSITY-WO2015/167825,2015,A1
Title: Development of second generation EP2 antagonists with high selectivity.
Journal: European journal of medicinal chemistry 20140723
Title: Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20120221
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501